These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 12754507)

  • 1. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages.
    Yasukawa H; Ohishi M; Mori H; Murakami M; Chinen T; Aki D; Hanada T; Takeda K; Akira S; Hoshijima M; Hirano T; Chien KR; Yoshimura A
    Nat Immunol; 2003 Jun; 4(6):551-6. PubMed ID: 12754507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS3 regulates the plasticity of gp130 signaling.
    Lang R; Pauleau AL; Parganas E; Takahashi Y; Mages J; Ihle JN; Rutschman R; Murray PJ
    Nat Immunol; 2003 Jun; 4(6):546-50. PubMed ID: 12754506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS3 negatively regulates IL-6 signaling in vivo.
    Croker BA; Krebs DL; Zhang JG; Wormald S; Willson TA; Stanley EG; Robb L; Greenhalgh CJ; Förster I; Clausen BE; Nicola NA; Metcalf D; Hilton DJ; Roberts AW; Alexander WS
    Nat Immunol; 2003 Jun; 4(6):540-5. PubMed ID: 12754505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.
    Niemand C; Nimmesgern A; Haan S; Fischer P; Schaper F; Rossaint R; Heinrich PC; Müller-Newen G
    J Immunol; 2003 Mar; 170(6):3263-72. PubMed ID: 12626585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.
    Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F
    J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.
    Williams L; Bradley L; Smith A; Foxwell B
    J Immunol; 2004 Jan; 172(1):567-76. PubMed ID: 14688368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
    Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
    Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
    Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
    Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of STAT3 and SOCS3 in pancreatic acinar cells.
    Vona-Davis LC; Frankenberry KA; Waheed U; Peterson E; McFadden DW
    J Surg Res; 2005 Jul; 127(1):14-20. PubMed ID: 15893771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
    Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation.
    Cassatella MA; Gasperini S; Bovolenta C; Calzetti F; Vollebregt M; Scapini P; Marchi M; Suzuki R; Suzuki A; Yoshimura A
    Blood; 1999 Oct; 94(8):2880-9. PubMed ID: 10515892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice.
    Kobayashi M; Kweon MN; Kuwata H; Schreiber RD; Kiyono H; Takeda K; Akira S
    J Clin Invest; 2003 May; 111(9):1297-308. PubMed ID: 12727921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A family of cytokine-inducible inhibitors of signalling.
    Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
    Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophages.
    Qasimi P; Ming-Lum A; Ghanipour A; Ong CJ; Cox ME; Ihle J; Cacalano N; Yoshimura A; Mui AL
    J Biol Chem; 2006 Mar; 281(10):6316-24. PubMed ID: 16352613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
    Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
    J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3.
    Shen X; Hong F; Nguyen VA; Gao B
    FEBS Lett; 2000 Sep; 480(2-3):132-6. PubMed ID: 11034314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced macrophage responsiveness to lipopolysaccharide and CD40 stimulation in a murine model of inflammatory bowel disease: IL-10-deficient mice.
    Takakura R; Kiyohara T; Murayama Y; Miyazaki Y; Miyoshi Y; Shinomura Y; Matsuzawa Y
    Inflamm Res; 2002 Aug; 51(8):409-15. PubMed ID: 12234058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic induction of IL-10 by hypertonic saline solution and lipopolysaccharides in murine peritoneal macrophages.
    Oreopoulos GD; Bradwell S; Lu Z; Fan J; Khadaroo R; Marshall JC; Li YH; Rotstein OD
    Surgery; 2001 Aug; 130(2):157-65. PubMed ID: 11490344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transducer and activator of transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92.
    Braunschweig A; Poehlmann TG; Busch S; Schleussner E; Markert UR
    Am J Reprod Immunol; 2011 Oct; 66(4):329-35. PubMed ID: 21385272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids increase interleukin-6-dependent gene induction by interfering with the expression of the suppressor of cytokine signaling 3 feedback inhibitor.
    Dittrich A; Khouri C; Sackett SD; Ehlting C; Böhmer O; Albrecht U; Bode JG; Trautwein C; Schaper F
    Hepatology; 2012 Jan; 55(1):256-66. PubMed ID: 21898505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.